Diagnostic Usefulness of Real-Time Elastography for Liver Fibrosis in Chronic Viral Hepatitis B and C

Table 1

Baseline characteristics of patients according to the histologic fibrosis stage.

Fibrosis stage	F0 ()	F1 ()	F3 ()	F4 ()	Total ()	value
HBV/HCV	5/9	13/13	17/9	16/1	51/32
Sex, male/female	8/6	16/10	18/8	12/5	54/29
Age, years	38 ± 11	47 ± 6	47 ± 10	48 ± 12	45 ± 10	0.031
BMI, kg/m^2	24.2 ± 2.5	24.1 ± 2.9	23.6 ± 3.5	24.0 ± 2.6	23.9 ± 2.9	0.912
AST, IU/L	59 ± 75	85 ± 85	82 ± 54	156 ± 207	94 ± 116	0.086
ALT, IU/L	101 ± 161	137 ± 177	134 ± 129	143 ± 182	131 ± 159	0.895
GGT, IU/L	73 ± 106	88 ± 111	62 ± 40	81 ± 82	76 ± 86	0.746
ALP, IU/L	89 ± 52	73 ± 24	85 ± 28	85 ± 33	82 ± 33	0.454
TB, mg/dL	1.3 ± 1.8	0.8 ± 0.2	1.0 ± 0.7	2.0 ± 3.2	1.2 ± 1.7	0.141
Albumin, g/dL	4.1 ± 0.4	4.0 ± 0.3	3.8 ± 0.4	3.4 ± 0.6	3.8 ± 0.5	0.000
Platelet, 10^3/mm^3	218 ± 63	207 ± 51	149 ± 52	128 ± 39	174 ± 62	0.000
PT INR	1.04 ± 0.09	1.06 ± 0.06	1.15 ± 0.12	1.22 ± 0.16	12.90 ± 1.60	0.000
Median CP score (Range)	5.36 (5~6)	5.21 (5~6)	5.36 (5~7)	5.83 (5~8)	5.39 (5~8)	0.028

HBV, hepatitis b virus; HCV, hepatitis c virus; BMI, body mass index; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; TB, total bilirubin; GGT, γ-glutamyl transpeptidase; PT INR, prothrombin time international normalized ratio; CP, Child-Pugh.